Epidemiology of peritoneal mesothelioma: a review

被引:193
|
作者
Boffetta, P. [1 ]
机构
[1] Int Agcy Res Canc, F-69008 Lyon, France
关键词
asbestos; epidemiology; peritoneal mesothelioma; thorotrast;
D O I
10.1093/annonc/mdl345
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The epidemiology of peritoneal mesothelioma is complicated by possible geographic and temporal variations in diagnostic practices. The incidence rates in industrialized countries range between 0.5 and three cases per million in men and between 0.2 and two cases per million in women. Exposure to asbestos is the main known cause of peritoneal mesothelioma. Results on peritoneal mesothelioma have been reported for 34 cohorts exposed to asbestos, among which a strong correlation was present between the percentages of deaths from pleural and peritoneal mesothelioma (correlation coefficient 0.8, P < 0.0001). Studies of workers exposed only or predominantly to chrysotile asbestos resulted in a lower proportion of total deaths from peritoneal mesothelioma than studies of workers exposed to amphibole or mixed type of asbestos. Cases of peritoneal mesothelioma have also been reported following exposure to erionite and Thorotrast, providing further evidence of common etiological factors with the pleural form of the disease. The role of other suspected risk factors, such as simian virus 40 infection and genetic predisposition, is unclear at present. Control of asbestos exposure remains the main approach to prevent peritoneal mesothelioma.
引用
收藏
页码:985 / 990
页数:6
相关论文
共 50 条
  • [1] Epidemiology of malignant peritoneal mesothelioma: A population-based study
    Salo, Silja A. S.
    Ilonen, Ilkka
    Laaksonen, Sanna
    Myllarniemi, Marjukka
    Salo, Jarmo A.
    Rantanen, Tuomo
    CANCER EPIDEMIOLOGY, 2017, 51 : 81 - 86
  • [2] PERITONEAL MESOTHELIOMA: DESCRIPTION OF A CASE AND REVIEW OF LITERATURE
    Pedata, P.
    Feola, D.
    Laieta, M. T.
    Garzillo, E. M.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2011, 24 (01) : 85 - 88
  • [3] Malignant peritoneal mesothelioma: a review
    Broeckx, Glenn
    Pauwels, Patrick
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 (05) : 537 - 542
  • [4] Immunotherapy in malignant peritoneal mesothelioma (Review)
    Alaklabi, Sabah
    Roy, Arya Mariam
    Skitzki, Joseph J.
    Iyer, Renuka
    MOLECULAR AND CLINICAL ONCOLOGY, 2023, 18 (04)
  • [5] Malignant peritoneal mesothelioma
    Munkholm-Larsen, Stine
    Cao, Christopher Q.
    Yan, Tristan D.
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2009, 1 (01): : 38 - 48
  • [6] Focus on Peritoneal Mesothelioma
    Ettahri, H.
    Akkar, O.
    Rais, S.
    Salmi, N.
    Lakhdissi, A.
    Layachi, M.
    Elamarti, L.
    Boutayeb, S.
    Errihani, H.
    JOURNAL AFRICAIN D HEPATO-GASTROENTEROLOGIE, 2016, 10 (04): : 179 - 183
  • [7] Mesothelioma - Epidemiology and Management
    Tai, Patricia
    Yu, Edward
    Assouline, Avi
    Joseph, Kurian
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2011, 7 (05) : 364 - 376
  • [8] Diffuse malignant peritoneal mesothelioma
    Shih, Chih-An
    Ho, Szu-Pei
    Tsay, Feng-Woei
    Lai, Kwok-Hung
    Hsu, Ping-I
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2013, 29 (11): : 642 - 645
  • [9] Peritoneal mesothelioma
    Mohamed F.
    Sugarbaker P.H.
    Current Treatment Options in Oncology, 2002, 3 (5) : 375 - 386
  • [10] Peritoneal mesothelioma
    Greenbaum, Alissa
    Alexander, H. Richard
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 : S120 - S132